Similar articles

• Is it time for a new approach to the initial treatment of hypertension?

  Moser M. Moser M. Arch Intern Med. 2001 May 14;161(9):1140-4. doi: 10.1001/archinte.161.9.1140. Arch Intern Med. 2001. PMID: 11343437 Review. No abstract available.
• Outcome beyond blood pressure control?

  Staessen JA, Wang JG, Birkenhäger WH. Staessen JA, et al. Eur Heart J. 2003 Mar;24(6):504-14. doi: 10.1016/s0195-668x(02)00797-2. Eur Heart J. 2003. PMID: 12643883 Review. No abstract available.
• HOPE-3, SPRINT, VALUE and a meta-analysis of trials in patients with diabetes support treatment of hypertension to a target below 140 mmHg.

  Kjeldsen SE, Hedner T, Narkiewicz K. Kjeldsen SE, et al. Blood Press. 2016 Jun;25(3):131-2. doi: 10.1080/08037051.2016.1182857. Epub 2016 May 10. Blood Press. 2016. PMID: 27160151 No abstract available.
• [Novel targets in the treatment of arterial hypertension].

  Khadzegova AB. Khadzegova AB. Kardiologiia. 2013;53(12):47-51. Kardiologiia. 2013. PMID: 24800481 Review. Russian. No abstract available.
• Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension.

  Waeber B, Mourad JJ. Waeber B, et al. Am J Hypertens. 2006 Sep;19(9):985-6. doi: 10.1016/j.amjhyper.2006.03.012. Am J Hypertens. 2006. PMID: 16942945 No abstract available.